For: | Shoji Y, Koyanagi K, Kanamori K, Tajima K, Ogimi M, Ninomiya Y, Yamamoto M, Kazuno A, Nabeshima K, Nishi T, Mori M. Immunotherapy for esophageal cancer: Where are we now and where can we go. World J Gastroenterol 2024; 30(19): 2496-2501 [PMID: 38817664 DOI: 10.3748/wjg.v30.i19.2496] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i19/2496.htm |
Number | Citing Articles |
1 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
|
2 |
Sung Eun Kim, Kyoungwon Jung, Moo In Park. Immunotherapy for Advanced/Metastatic Esophageal Squamous Cell Carcinoma. Journal of Digestive Cancer Research 2024; 12(2): 72 doi: 10.52927/jdcr.2024.12.2.72
|
3 |
Grigorios Christodoulidis, Sara Eirini Agko, Konstantinos Eleftherios Koumarelas, Marina Nektaria Kouliou, Dimitris Zacharoulis. Advancements and challenges in the treatment of esophageal cancer: A comprehensive review. World Journal of Clinical Oncology 2024; 15(12): 1463-1467 doi: 10.5306/wjco.v15.i12.1463
|
4 |
Yoshiaki Shoji, Kohei Kanamori, Kazuo Koyanagi, Tetsuya Otsuka, Rie Nakashima, Kohei Tajima, Mika Ogimi, Yamato Ninomiya, Miho Yamamoto, Akihito Kazuno, Takayuki Nishi, Masaki Mori. Conversion surgery for esophageal and esophagogastric junction cancer. International Journal of Clinical Oncology 2024; doi: 10.1007/s10147-024-02639-4
|